SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical development SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug and display” vaccine platform technology Braavos Investment Advisers led the round, joined by new investor Oxford Investment […]
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman Read More »